WHO Also Updates Its Recommendation on Casirivimab-imdevimab, a Monoclonal Antibody ... - Latest Tweet by World Health Organization

WHO also updates its recommendation on casirivimab-imdevimab, a monoclonal antibody cocktail.

Based on evidence that this combination of drugs is ineffective against the Omicron, WHO now recommends that it is only given when the #COVID19 infection is caused by another variant.— World Health Organization (WHO) (@WHO) March 3, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)